Literature DB >> 22162614

Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.

Reid R Hoshide1, Heath Chung, Jinichi Tokeshi.   

Abstract

Community-acquired extended-spectrum beta-lactamase E coli (ESBLEC) have not been previously described in Honolulu. Its emergence as a community-acquired pathogen is concerning. This case series describes three patients who were diagnosed with community-acquired ESBLEC bacteriuria in 2010.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22162614      PMCID： PMC3233400     

Source DB:  PubMed          Journal:  Hawaii Med J        ISSN： 0017-8594


  27 in total

Review 1.  Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review.

Authors:  S Segal-Maurer; N Mariano; A Qavi; C Urban; J J Rahal
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

2.  Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis.

Authors:  D L Paterson; N Singh; T Gayowski; I R Marino
Journal:  Clin Infect Dis       Date:  1999-03       Impact factor: 9.079

3.  Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.

Authors:  R Colodner; W Rock; B Chazan; N Keller; N Guy; W Sakran; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

4.  Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens.

Authors:  G Jacoby; P Han; J Tran
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

5.  A novel plasmid-mediated extended-spectrum beta-lactamase not derived from TEM- or SHV-type enzymes.

Authors:  H Bernard; C Tancrede; V Livrelli; A Morand; M Barthelemy; R Labia
Journal:  J Antimicrob Chemother       Date:  1992-05       Impact factor: 5.790

6.  Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases.

Authors:  A Bauernfeind; I Stemplinger; R Jungwirth; S Ernst; J M Casellas
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

7.  Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation.

Authors:  D A Schiappa; M K Hayden; M G Matushek; F N Hashemi; J Sullivan; K Y Smith; D Miyashiro; J P Quinn; R A Weinstein; G M Trenholme
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

Review 8.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

9.  Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins.

Authors:  K S Meyer; C Urban; J A Eagan; B J Berger; J J Rahal
Journal:  Ann Intern Med       Date:  1993-09-01       Impact factor: 25.391

10.  Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients.

Authors:  L Naumovski; J P Quinn; D Miyashiro; M Patel; K Bush; S B Singer; D Graves; T Palzkill; A M Arvin
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191
View more
  1 in total

1.  Emergence of Raoultella ornithinolytica on O'ahu: a case of community-acquired R. ornithinolytica urinary tract infection.

Authors:  Elizabeth S Nakasone; Ricky Kaneshiro; Kathleen Min; Jinichi Tokeshi
Journal:  Hawaii J Med Public Health       Date:  2015-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.